Medline (MDLN) Non-Current Debt (2024 - 2026)

Medline (MDLN) posted quarterly Non-Current Debt of $12.5 billion for Q1 2026, little changed quarter-over-quarter from $12.5 billion in Q4 2025.

Medline (MDLN) Non-Current Debt (2024 - 2026) Analysis & Trends

Medline (MDLN) has reported Non-Current Debt for 3 consecutive years, with $12.5 billion the latest figure, recorded in Q1 2026.

In Q1 2026, Non-Current Debt changed N/A year-over-year to $12.5 billion; the TTM figure through Mar 2026 stood at $12.5 billion (changed N/A YoY), while the FY2025 annual figure was $12.5 billion, down 23.95% from the prior year.
Non-Current Debt held at $12.5 billion in Q1 2026 per MDLN's latest filing, from $12.5 billion in the prior quarter.
Across five years, Non-Current Debt topped out at $16.4 billion in Q4 2024 and bottomed at $12.5 billion in Q4 2025.
Historically, Non-Current Debt has averaged $13.8 billion across 3 years, with a median of $12.5 billion in 2026.
On a YoY basis, Non-Current Debt climbed as much as 23.95% in 2025 and fell as far as 23.95% in 2025.
Medline's Non-Current Debt stood at $16.4 billion in 2024, then retreated by 23.95% to $12.5 billion in 2025, then rose by 0.09% to $12.5 billion in 2026.
Business Quant data shows MDLN's Non-Current Debt at $12.5 billion in Q1 2026, $12.5 billion in Q4 2025, and $16.4 billion in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	-
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	13.51 Bn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	4.15 Bn
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	399.42 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	12.55 Bn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	202.90 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	4.57 Bn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	1.86 Bn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	8.62 Bn
10	Align Technology	11.61 Bn	10.51 Bn	757.43 Mn	-

Download Data